Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: August 20, 2018

DrugPatentWatch Database Preview

Pharmadax Inc Company Profile

« Back to Dashboard

What is the competitive landscape for PHARMADAX INC, and what generic and branded alternatives to PHARMADAX INC drugs are available?

PHARMADAX INC has three approved drugs.

Summary for Pharmadax Inc

US Patents:	0
Tradenames:	3
Ingredients:	3
NDAs:	3
Patent Litigation for Pharmadax Inc:	See patent lawsuits for Pharmadax Inc

Drugs and US Patents for Pharmadax Inc

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pharmadax Inc	GLYBURIDE	glyburide	TABLET;ORAL	203581-003	Apr 14, 2016	AB1	RX	No	No		➤ Sign Up				➤ Sign Up
Pharmadax Inc	GLYBURIDE	glyburide	TABLET;ORAL	203581-001	Apr 14, 2016	AB1	RX	No	No		➤ Sign Up				➤ Sign Up
Pharmadax Inc	LEVETIRACETAM	levetiracetam	TABLET, EXTENDED RELEASE;ORAL	201464-002	May 25, 2012	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Pharmadax Inc	GLYBURIDE	glyburide	TABLET;ORAL	203581-002	Apr 14, 2016	AB1	RX	No	No		➤ Sign Up				➤ Sign Up
Pharmadax Inc	QUETIAPINE FUMARATE	quetiapine fumarate	TABLET, EXTENDED RELEASE;ORAL	206260-002	May 9, 2017	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Pharmadax Inc	QUETIAPINE FUMARATE	quetiapine fumarate	TABLET, EXTENDED RELEASE;ORAL	206260-003	May 9, 2017	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar

QuintilesIMS

Chinese Patent Office

Covington

Fish and Richardson

Argus Health

Medtronic

Fuji

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.